Amicus Therapeutics

Last updated: July 23, 2024

CEO John Crowley
CEO John Crowley
USA | Funding: $2.4B (+)

Website: https://www.amicusrx.com/

Amicus Therapeutics is a biotechnology company at the forefront of advanced therapies to treat a range of devastating rare and orphan diseases.